The latest announcement is out from Biotron Limited ( (AU:BIT) ).
Biotron Limited has updated its timetable for a rights issue initially announced on 28 February 2025. Following feedback from the Australian Securities and Investments Commission (ASIC) and the ASX, a replacement prospectus was lodged on 12 March 2025. The updated schedule outlines key dates, including the opening of the offer on 18 March 2025 and the expected commencement of normal trading of new shares on 9 April 2025. This rights issue provides eligible shareholders the opportunity to acquire additional shares, potentially impacting the company’s capital structure and market position.
More about Biotron Limited
Biotron Limited is a company operating in the biotechnology industry, focusing on the development of antiviral drugs. The company is listed on the Australian Securities Exchange (ASX) under the ticker BITR.
YTD Price Performance: 390.0%
Average Trading Volume: 31,750
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $3.41M
See more insights into BIT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com